ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Announce Strategic Partnership to Enhance Access to High-Quality Antibodies

Cambridge - August 28th 2025 - Antibodies.com, a trusted provider of high-quality antibodies and research reagents, is proud to announce a strategic partnership with Carl Roth, a leading supplier of laboratory and research chemicals. This collaboration represents an important milestone, expanding access to Antibodies.com’s cutting-edge portfolio for Carl Roth’s customers across Europe.

Through this partnership, Carl Roth will distribute Antibodies.com’s extensive collection of antibodies and immunoassays - including monoclonal, polyclonal, and recombinant products - designed to meet the needs of researchers in academia, biotechnology, and the pharmaceutical industry. With a strong reputation for quality, reliability, and affordability, Antibodies.com complements Carl Roth’s mission to deliver best-in-class solutions for scientific discovery.

"We are excited to partner with Carl Roth, a company that shares our dedication to advancing scientific research," said Sebastian Newlove, Co-Founder of Antibodies.com. "Together, we aim to make high-quality antibodies more accessible, enabling researchers to achieve their goals with confidence and efficiency."

Dr. Leonie Hacker, Head of Product Management Chemistry & Life Science at Carl Roth, added: "This partnership represents a significant step forward in our commitment to empowering researchers with the best tools available. By integrating Antibodies.com’s high-quality antibodies into our offerings, we are ensuring that our customers have access to innovative products at fair prices, supporting their groundbreaking work in life sciences."

Antibodies.com’s customer-focused approach - emphasising transparency, rigorous quality control, and exceptional value - combined with Carl Roth’s established distribution network, will streamline access to these products, ensuring seamless delivery and support for researchers across Europe.

This collaboration underscores the shared vision of both companies: to foster innovation and excellence within the scientific community. Researchers can now explore Antibodies.com’s antibody portfolio through Carl Roth’s online platform or by contacting their sales representatives for tailored support.

For more information about this partnership or to browse the expanded product offerings, visit www.antibodies.com or www.carlroth.com.

About Carl Roth

Carl Roth, headquartered in Karlsruhe, Germany, is a leading distributor of laboratory supplies, chemicals, and equipment. With a legacy of excellence spanning decades, Carl Roth serves researchers and professionals in life sciences, chemistry, and beyond, delivering high-quality products and exceptional customer service.

About Antibodies.com

Antibodies.com is a global provider of high-quality antibodies and research reagents, dedicated to supporting scientific discovery. With a focus on affordability, reliability, and innovation, Antibodies.com empowers researchers with the tools they need to advance their work in immunology, oncology, and other critical fields.

Media Contact
Company Name: antibodies.com
Contact Person: Christian Lautenschlager
Email: Send Email
Phone: + 44 (0)1223 298 875
Country: United Kingdom
Website: Antibodies.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.